Sunday, September 29, 2019 11:49:27 AM
_____________________________________________________________________________________________
Transgenic rat model:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151290355
3-71 and Alzheimer's
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151290584
Falconer on commonalities of CNS disease:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145055598
Opportunities for treatment with Anavex 2-73 and/or Anavex 3-71 (from georgejjl)
Image from AVXL presentation, clipped by georgej
Origin of 3-71
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148063609
3-71 preclinical and IP information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148063670
3-71 is more potent:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149158581&txt2find=71
AF710B (aka ANAVEX 3-71) preclinical studies (from georgejjl)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409318/
Comments on the above:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148105642
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148106820
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148110087
Biostockclub - on comparison of 2-73 and 3-71
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147042220
(see response by Falconer66a also)
Seminal Findings in the Anavex 3-71 Rat Study (from falconer66a)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147056303
3-71 articles from McGill coming:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147109223
ANAVEX 3-71 additional information from 2016 (from georgejjl)
https://www.karger.com/Article/Fulltext/440864
Anavex 2-73 and Anavex 3-71 as a treatment for PTSD (Posttraumatic Stress Disorders)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148757940&txt2find=71
On the science of 3-71
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147390529
McGill Powerpoint on 3-71 (from georgejjl)
https://anavex.com/wp-content/uploads/170330_ADPD-Vienna_HH-update.pdf
2-73 vs 3-71 and the new sleep post tying taupathologies to sleep and synaptic loss
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147042220
Why 2-73 was first (maybe):
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147015651
Murine data show 3-71 to be even more powerful than Anavex 2-73
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146991629
Recent AVXL News
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/12/2024 09:45:00 AM
- Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 04/02/2024 09:45:00 AM
- Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 03/29/2024 09:45:00 AM
- Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 03/26/2024 09:45:00 AM
- Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
- The Gross Law Firm Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 03/22/2024 09:45:00 AM
- Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia • GlobeNewswire Inc. • 03/18/2024 11:30:00 AM
- Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference • GlobeNewswire Inc. • 02/26/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:05:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:04:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:04:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:03:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:03:06 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/07/2024 09:31:07 PM
- Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/07/2024 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM